Barings’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-8,529
Closed -$665K 957
2016
Q2
$665K Sell
8,529
-3,900
-31% -$278K 0.02% 587
2016
Q1
$684K Sell
12,429
-7,800
-39% -$425K 0.02% 594
2015
Q4
$1.25M Hold
20,229
0.03% 428
2015
Q3
$1.28M Buy
20,229
+5,900
+41% +$421K 0.03% 400
2015
Q2
$1.05M Sell
14,329
-3,100
-18% -$224K 0.03% 496
2015
Q1
$1.14M Sell
17,429
-7,400
-30% -$492K 0.03% 477
2014
Q4
$1.61M Hold
24,829
0.04% 356
2014
Q3
$1.49M Hold
24,829
0.03% 375
2014
Q2
$1.72M Hold
24,829
0.05% 354
2014
Q1
$1.62M Hold
24,829
0.05% 336
2013
Q4
$1.54M Sell
24,829
-2,700
-10% -$156K 0.06% 324
2013
Q3
$1.48M Buy
27,529
+3,600
+15% +$185K 0.06% 335
2013
Q2
$1.09M Buy
+23,929
New +$1.04M 0.05% 386

Other funds holding STJ

Barings's STJ Position: Q3 2016 in Review

Barings sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 8,529 shares — an estimated $665K sold.

Barings first reported a position in STJ in Q2 2013 and held it in 13 quarters. The position peaked at $1.72M in Q2 2014. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Barings reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • Barings sold 8,529 St Jude Medical shares in Q3 2016, an estimated $665K.
  • Barings first reported a position in St Jude Medical in Q2 2013 and held it in 13 quarters.
  • Barings's St Jude Medical position peaked at $1.72M in Q2 2014.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Barings's 13F filing for Q3 2016, filed 14 Nov 2016.